Clinical Trial Update: Triple Versus Dual Antiplatelet Therapy After ABT578-Eluting Stent [Phase 4]

View source ↗

Summary

Phase 4 clinical trial comparing triple versus dual antiplatelet therapy after ABT-578–eluting stents has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Coronary Artery Disease

Drugs mentioned

• ABT-578 (clopidogrel)

Snippet

Sponsor: CardioVascular Research Foundation, Korea | Conditions: Coronary Artery Disease | Phase 4 | Status: COMPLETED